Hussnain Javaid: The Importance of Targeted Examination in Iron Deficiency Anaemia
Hussnain Javaid, Consultant Haematologist at NHS UK, Founder of ClinHaem, shared a post on LinkedIn:
“Investigations without history and examination can be blind!
You are seeing a 52-year-old White Caucasian man in the clinic who has been referred to you for further evaulation of his recurrent iron deficiency anaemia.
Background
- Hypertension only
- Medications: Ramipril, intermittent oral iron over several years
History
- 5-year history of recurrent iron deficiency anaemia detected on routine blood tests
- Multiple courses of oral iron with only transient improvement
- Required two intravenous iron infusions in the past 2 years
- Ferritin rises with treatment but falls again after cessation
- Absolutely denies gastrointestinal symptoms including abdominal pain, change in bowel habit or overt GI bleeding including malena.
- No bleeding in the urine.
- Stools and urine are normal color.
- Has repeatedly declined OGD and colonoscopy
Additional history reveals
- Intermittent epistaxis
- No excessive bleeding despite three previous major orthopaedic surgeries involving the knee joint and femur following trauma
- Father also required recurrent intravenous iron infusions
Blood tests
Hb: 102 g/L (130–180)
MCV: 74 fL (80–100)
MCH: 23 pg (27–32)
Platelets: 410 ×10⁹/L (150–400)
Ferritin: 14 µg/L (30–300)
PT: 12.1 s (11–14)
APTT: 29 s (25–35)
Fibrinogen: 3.1 g/L (2.0–4.0)
VWF:Ag: 108 IU/dL (50–200)
VWF:Act (RCoF): 96 IU/dL (50–200)
Factor VIII: 118 IU/dL (50–150)
Question
Which of the following is the most appropriate targeted clinical examination to help identify the underlying diagnosis?
Options
A. Examination of the skin and joints
B. Examination of the conjunctivae and nails
C. Examination of the lips, oral mucosa and fingertips
D. Examination of the spleen and lymph nodes
E. Examination of dependent areas of the skin
Please provide a brief explanation of your answer as well.
Answer out later on!
P.S. week 4 and 5 = Thalassaemia and SCD respectively so stay tuned for some haemoglobinopathy questions!
Details on ClinHaem.”

Stay updated with Hemostasis Today.
-
Jul 13, 2026, 14:42Bruno Pougault: The Global Momentum Behind Innovation in Thrombosis and Hemostasis
-
Jul 13, 2026, 14:34Julie Vassart: Optimizing DOAC Detection in an Evolving Anticoagulant Landscape at ISTH 2026
-
Jul 13, 2026, 13:57Heghine Khachatryan: The Diagnostic Dilemma of Non-Criteria Obstetric APS
-
Jul 13, 2026, 13:49Mitra Najafi: Translating Years of Innovation into Global Scientific Dialogue at ISTH 2026
-
Jul 13, 2026, 13:2810 Posts Not To Miss from ISTH 2026, Part 2
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026